Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

ClinicalTrials.gov ID: NCT00463047

Public ClinicalTrials.gov record NCT00463047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate-release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patient With Chronic Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the efficacy of treatment with Fentanyl Buccal Tablets (FBT) compared with immediate release oxycodone in alleviating breakthrough pain in opioid tolerant patients with chronic pain.

Study identification

NCT ID
NCT00463047
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
323 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Feb 2009 (Actual)
Completion
Feb 2009 (Actual)
Last update posted
May 28, 2012

2007 – 2009

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35235 —
Birmingham Pain Center Birmingham Alabama 35244 —
Arizona Research Center Phoenix Arizona 85023 —
Desert Pain & Rehab Specialists/Redpoint Research Phoenix Arizona 85029 —
Hope Research Institute Phoenix Arizona 85050 —
Lovelace Scientific Resources, Inc. Beverly Hills California 90211 —
City of Hope National Medical Center Duarte California 91010 —
Samaritan Center for Medical Research, Med. Group Los Gatos California 95032 —
Advanced Diagnostic Pain Treatment Center, PC New Haven Connecticut 06511 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Compass Research Orlando Florida 32806 —
AvivoClin Clinical Services Port Orange Florida 32127 —
Lovelace Scientific Resources, Inc. Sarasota Florida 34233 —
Clinical Research of Tampa Bay, Inc. Spring Hill Florida 34609 —
Stedman Clinical Trials, LLC Tampa Florida 33613 —
Center for Prospective Outcome Studies, Inc. Atlanta Georgia 30327 —
North Georgia Premier Research Dawnsonville Georgia 30534 —
Taylor Research, LLC Marietta Georgia 30060 —
DrugStudies America Marietta Georgia 30066 —
Tristate Arthritis & Rheumatology Center, LLC Evansville Indiana 47714 —
Rehabilitation Associates of Indiana Indianapolis Indiana 46250 —
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265 —
International Clinical Research Institute, Inc. Overland Park Kansas 66211 —
Kansas City Bone & Joint Clinic, Inc. Overland Park Kansas 66211 —
Willis-Knighton Pain Management Center Shreveport Louisiana 71103 —
The Rehabilitation Team West Baltimore Maryland 21228 —
Mid Atlantic Pain Medicine Center Pikesville Maryland 21208 —
Englewood Hospital and Medical Center Englewood New Jersey 07631 —
Lovelace Scientific Resources, Inc. Albuquerque New Mexico 87108 —
Metropolitan Hospital Center New York New York 10029 —
Mount Sinai School of Medicine New York New York 10029 —
Duke University Medical Center Durham North Carolina 27710 —
PharmQuest Greensboro North Carolina 27401 —
Peters Medical Research High Point North Carolina 27262 —
Raleigh Neurology Associate Raleigh North Carolina 27607 —
Columbus Clinical Research Columbus Ohio 43213 —
Allegheny Pain Management Altoona Pennsylvania 16602 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
University of Pennsylvania Philadelphia Pennsylvania 19146 —
Greenville Pharmaceutical Greenville South Carolina 29615 —
Comprehensive Pain Specialists, PLLC Hendersonville Tennessee 37075 —
Consultants in Pain Research San Antonio Texas 78209 —
InVisions Consultants, LLC San Antonio Texas 78218 —
Northwest Clinical Research Center Bellevue Washington 98004 —
The Center for Pain Relief Charleston West Virginia 25301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00463047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2012 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00463047 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →